Skip to main content
. 2021 Nov 18;16(4):97–101. doi: 10.5489/cuaj.7451

Fig. 1.

Fig. 1

Flow chart of small renal mass (SRM)-renal cell carcinoma (RCC) patients progressing onto treatment. Progression defined as growth >0.5 cm/year for two years, absolute size >4 cm, volume doubling <1 year. AS: active surveillance.